Evidence map›Paper›PMID 41358070›Full record

ArticleACS omega2025

Andrographolide Selectively Inhibits the Growth of LA7 Mammary Adenocarcinoma Cells.

Kallol Roy, Parthiv Kar, Saikat Haldar, Sarangthem Dinamani Singh, Selvaraman Nagamani, Himangsu K Bora, Binoy K Saikia, Rituraj Konwar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kallol RoyCentre for Preclinical Studies (CPS), Biological Sciences and Technology Division (BSTD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.
Parthiv KarCentre for Preclinical Studies (CPS), Biological Sciences and Technology Division (BSTD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.
Saikat HaldarCentre for Preclinical Studies (CPS), Biological Sciences and Technology Division (BSTD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.
Sarangthem Dinamani SinghAdvanced Computation and Data Sciences Division (ACDSD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.
Selvaraman NagamaniAdvanced Computation and Data Sciences Division (ACDSD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.ORCID https://orcid.org/0000-0002-7825-3994
Himangsu K BoraCentre for Preclinical Studies (CPS), Biological Sciences and Technology Division (BSTD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.
Binoy K SaikiaCoal and Energy Group (C&E), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.ORCID https://orcid.org/0000-0002-3382-6218
Rituraj KonwarCentre for Preclinical Studies (CPS), Biological Sciences and Technology Division (BSTD), CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat 785006, Assam, India.ORCID https://orcid.org/0000-0002-3740-8363

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) causes significant mortality and morbidity, specifically in women globally. The first line of available therapies are far from satisfactory due to their adverse side effects, drug resistance, and reoccurrence of the cancer. As a result, natural source-based complementary medicines with anticancer activity and lesser side effects are widely investigated. Andrographolide (AGL), an active phytomolecule of

Identifiers

PMID41358070
PMCPMC12676339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.